PIII P3 Health Partners Inc.
Nasdaq · SEC CIK 1832511 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $823.9K 1 sales by 1 insiders
- Filings on record
- 92 since 2021-10-06, latest 2026-08-14 17:00
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Hudson Vegas Investment SPV, LLC | 10% | — | $823.9K |
Transactions 76
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-08-14 17:00 | 2026-08-13 | PIII | Hudson Vegas Investment SPV, LLC | 10% | C - Cnv Deriv | — | +100.0K | 100.0K | New | — |
| D | 2026-08-14 17:00 | 2026-08-13 | PIII | Hudson Vegas Investment SPV, LLC | 10% | J - Other | — | -100.0K | 729.7K | -12% | — |
| M | 2026-08-12 16:30 | 2026-08-10 | PIII | Hudson Vegas Investment SPV, LLC | 10% | S - Sale | $16.48 | -50.0K | 0 | -100% | -$823.9K |
| D | 2026-06-12 17:31 | 2026-06-10 | PIII | Hudson Vegas Investment SPV, LLC | 10% | C - Cnv Deriv | — | +50.0K | 50.0K | New | — |
| D | 2026-06-12 17:31 | 2026-06-10 | PIII | Hudson Vegas Investment SPV, LLC | 10% | J - Other | — | -50.0K | 829.7K | -6% | — |
| A | 2026-01-23 | 2025-08-06 | PIII | Leisure Lawrence B. | Dir | A - Grant | $0.00 | +2,000 | 6,331 | +46% | $0 |
| A | 2026-01-23 | 2025-08-06 | PIII | TOLAN MARY A | Dir | A - Grant | $0.00 | +2,000 | 6,331 | +46% | $0 |
| A | 2026-01-23 | 2025-08-06 | PIII | Kazarian Gregory N. | Dir | A - Grant | $0.00 | +2,000 | 6,331 | +46% | $0 |
| A | 2026-01-23 | 2025-08-06 | PIII | WASSON GREGORY D | Dir | A - Grant | $0.00 | +2,000 | 6,331 | +46% | $0 |
| A | 2026-01-23 | 2025-08-06 | PIII | Price Thomas Edmunds | Dir | A - Grant | $0.00 | +2,000 | 6,331 | +46% | $0 |
| A | 2026-01-23 | 2025-08-06 | PIII | Park Jeffrey G | Dir | A - Grant | $0.00 | +2,000 | 6,331 | +46% | $0 |
| A | 2026-01-23 | 2025-08-06 | PIII | Thierer Mark | Dir | A - Grant | $0.00 | +4,000 | 12.7K | +46% | $0 |
| 2025-08-08 | 2025-08-06 | PIII | Kazarian Gregory N. | Dir | A - Grant | $0.00 | +2,000 | 218.6K | +0.9% | $0 | |
| 2025-08-08 | 2025-08-06 | PIII | WASSON GREGORY D | Dir | A - Grant | $0.00 | +2,000 | 218.6K | +0.9% | $0 | |
| 2025-08-08 | 2025-08-06 | PIII | Leisure Lawrence B. | Dir | A - Grant | $0.00 | +2,000 | 218.6K | +0.9% | $0 | |
| 2025-08-08 | 2025-08-06 | PIII | Thierer Mark | Dir | A - Grant | $0.00 | +4,000 | 437.1K | +0.9% | $0 | |
| 2025-08-08 | 2025-08-06 | PIII | TOLAN MARY A | Dir | A - Grant | $0.00 | +2,000 | 218.6K | +0.9% | $0 | |
| 2025-08-08 | 2025-08-06 | PIII | Price Thomas Edmunds | Dir | A - Grant | $0.00 | +2,000 | 218.6K | +0.9% | $0 | |
| 2025-08-08 | 2025-08-06 | PIII | Park Jeffrey G | Dir | A - Grant | $0.00 | +2,000 | 218.6K | +0.9% | $0 | |
| MI | 2024-09-13 | 2024-09-12+ | PIII | CPF III-A PT SPV, LLC | 10% | P - Purchase | $0.51 | +160.0K | 77.19M | +0.2% | +$81.6K |
| MI | 2024-09-12 | 2024-09-09+ | PIII | Chicago Pacific Founders GP III, L.P. | 10% | P - Purchase | $0.5367 | +240.0K | 76.95M | +0.3% | +$128.8K |
| MI | 2024-09-11 | 2024-09-04+ | PIII | Chicago Pacific Founders UGP III, LLC | 10% | P - Purchase | $0.49 | +240.0K | 76.71M | +0.3% | +$117.6K |
| AI | 2024-09-10 | 2023-09-14 | PIII | CPF III PT SPV, LLC | 10% | P - Purchase | $2.52 | +90.0K | 50.12M | +0.2% | +$226.8K |
| DI | 2024-06-26 | 2024-05-24 | PIII | LEAVITT LEGACY, LLC | 10% | P - Purchase | — | +7.97M | 16.92M | +89% | — |
| 2024-01-25 | 2023-10-23 | PIII | Park Jeffrey G | Dir | A - Grant | $0.00 | +216.6K | 216.6K | New | $0 | |
| 2024-01-25 | 2023-10-23 | PIII | Kazarian Gregory N. | Dir | A - Grant | $0.00 | +216.6K | 216.6K | New | $0 | |
| 2024-01-25 | 2023-10-23 | PIII | Price Thomas Edmunds | Dir | A - Grant | $0.00 | +216.6K | 216.6K | New | $0 | |
| 2024-01-25 | 2023-10-23 | PIII | WASSON GREGORY D | Dir | A - Grant | $0.00 | +216.6K | 216.6K | New | $0 | |
| 2024-01-25 | 2023-10-23 | PIII | Leisure Lawrence B. | Dir | A - Grant | $0.00 | +216.6K | 216.6K | New | $0 | |
| 2024-01-25 | 2023-10-23 | PIII | Thierer Mark | Dir | A - Grant | $0.00 | +433.1K | 433.1K | New | $0 | |
| 2024-01-25 | 2023-10-23 | PIII | TOLAN MARY A | Dir | A - Grant | $0.00 | +216.6K | 216.6K | New | $0 | |
| 2024-01-17 | 2024-01-09 | PIII | Bacchus Amir | Chief Medical Off, Dir | J - Other | — | +287.1K | 2.01M | +17% | — | |
| 2024-01-17 | 2024-01-09 | PIII | Abdou Sherif | CEO, Dir, 10% | J - Other | — | +483.9K | 1.61M | +43% | — | |
| 2024-01-03 | 2023-12-31 | PIII | Abdou Sherif | CEO, Dir, 10% | F - Tax | $1.41 | -483.9K | 1.12M | -30% | -$682.3K | |
| 2024-01-03 | 2023-12-31 | PIII | Bacchus Amir | Chief Medical Off, Dir | F - Tax | $1.41 | -287.1K | 1.72M | -14% | -$404.8K | |
| AI | 2023-10-04 | 2023-09-01 | PIII | CPF III PT SPV, LLC | 10% | P - Purchase | $2.07 | +90.0K | 49.31M | +0.2% | +$186.3K |
| AI | 2023-10-04 | 2023-09-11 | PIII | CPF III PT SPV, LLC | 10% | P - Purchase | $2.52 | +90.0K | 49.85M | +0.2% | +$226.8K |
| MAI | 2023-10-04 | 2023-09-05+ | PIII | CPF III PT SPV, LLC | 10% | P - Purchase | $2.07 | +270.0K | 49.58M | +0.5% | +$558.9K |
| MAI | 2023-10-04 | 2023-09-11+ | PIII | CPF III PT SPV, LLC | 10% | P - Purchase | $2.54 | +270.0K | 49.76M | +0.5% | +$685.8K |
| I | 2023-09-15 | 2023-09-11 | PIII | CPF III-A PT SPV, LLC | 10% | P - Purchase | $2.52 | +90.0K | 50.12M | +0.2% | +$226.8K |
| MI | 2023-09-13 | 2023-09-11+ | PIII | CPF III PT SPV, LLC | 10% | P - Purchase | $2.54 | +270.0K | 50.03M | +0.5% | +$685.8K |
| MI | 2023-09-07 | 2023-09-05+ | PIII | Chicago Pacific Founders GP III, L.P. | 10% | P - Purchase | $2.07 | +270.0K | 49.58M | +0.5% | +$558.9K |
| 2023-09-01 | 2023-08-02 | PIII | Kavthekar Atul | CFO | A - Grant | $0.00 | +750.0K | 768.9K | +3,975% | $0 | |
| MI | 2023-09-01 | 2023-08-31+ | PIII | Chicago Pacific Founders GP III, L.P. | 10% | P - Purchase | $2.08 | +180.0K | 49.40M | +0.4% | +$375.3K |
| MI | 2023-08-30 | 2023-08-28+ | PIII | Chicago Pacific Founders UGP III, LLC | 10% | P - Purchase | $1.64 | +270.0K | 49.22M | +0.6% | +$442.8K |
| MI | 2023-08-28 | 2023-08-24+ | PIII | CPF III-A PT SPV, LLC | 10% | P - Purchase | $1.47 | +180.0K | 48.95M | +0.4% | +$264.6K |
| 2023-08-08 | 2023-08-04 | PIII | Abdou Sherif | CEO, Dir, 10% | A - Grant | $0.00 | +1.50M | 1.61M | +1,386% | $0 | |
| 2023-08-08 | 2023-08-04 | PIII | Bacchus Amir | Chief Medical Off, Dir | A - Grant | $0.00 | +1.00M | 2.01M | +99% | $0 | |
| MI | 2023-06-02 | 2023-05-31+ | PIII | CPF III PT SPV, LLC | 10% | P - Purchase | $3.98 | +95.8K | 48.86M | +0.2% | +$381.8K |
| MI | 2023-05-30 | 2023-05-25+ | PIII | Chicago Pacific Founders UGP III, LLC | 10% | P - Purchase | $3.90 | +245.9K | 48.78M | +0.5% | +$958.0K |
| MI | 2023-05-24 | 2023-05-22+ | PIII | Chicago Pacific Founders UGP III, LLC | 10% | P - Purchase | $3.92 | +230.4K | 48.64M | +0.5% | +$904.1K |
| MI | 2023-05-19 | 2023-05-17+ | PIII | Chicago Pacific Founders GP III, L.P. | 10% | P - Purchase | $3.43 | +270.0K | 48.28M | +0.6% | +$927.0K |
| MAI | 2023-05-19 | 2023-05-17+ | PIII | Chicago Pacific Founders GP III, L.P. | 10% | P - Purchase | $3.48 | +270.0K | 48.46M | +0.6% | +$938.7K |
| MI | 2023-05-17 | 2023-05-15+ | PIII | CPF III-A PT SPV, LLC | 10% | P - Purchase | $3.12 | +180.0K | 48.19M | +0.4% | +$562.5K |
| 2023-05-16 | 2023-05-15 | PIII | Kavthekar Atul | CFO | P - Purchase | $2.65 | +18.9K | 18.9K | New | +$50.0K | |
| 2023-05-16 | 2023-05-12 | PIII | Abdou Sherif | CEO, Dir, 10% | P - Purchase | $2.63 | +108.2K | 108.2K | New | +$284.6K | |
| DI | 2023-04-28 | 2023-04-06 | PIII | Chicago Pacific Founders GP, L.P. | 10% | P - Purchase | $1.18 | +4.74M | 104.74M | +5% | +$5.59M |
| DMI | 2023-04-19 | 2023-04-06 | PIII | LEAVITT LEGACY, LLC | 10% | A - Grant | — | +9.84M | 8.94M | New | — |
| DI | 2023-04-10 | 2023-04-06 | PIII | Bacchus Amir | Chief Medical Off, Dir | A - Grant | — | +251.3K | 251.3K | New | — |
| D | 2023-04-10 | 2023-04-06 | PIII | Bacchus Amir | Chief Medical Off, Dir | A - Grant | — | +1.01M | 1.01M | New | — |
| DA | 2022-02-15 | 2021-12-03 | PIII | Kazarian Gregory N. | Dir | A - Grant | $70.66 | +706.6K | 706.6K | New | +$49.93M |
| DAI | 2022-02-15 | 2021-12-03 | PIII | Kazarian Gregory N. | Dir | A - Grant | $47.11 | +471.1K | 471.1K | New | +$22.19M |
| DI | 2022-01-31 | 2022-01-28 | PIII | Balkin Michael | 10% | P - Purchase | $4.83 | +15.0K | 7.55M | +0.2% | +$72.5K |
| DAI | 2022-01-21 | 2022-01-19 | PIII | Balkin Michael | 10% | P - Purchase | $5.10 | +4,239 | 7.53M | +0.1% | +$21.6K |
| DMI | 2021-12-07 | 2021-12-03 | PIII | Abdou Sherif | CEO, Dir, 10% | A - Grant | $737.95 | +28.19M | 1.41M | New | +$20.80B |
| D | 2021-12-07 | 2021-12-03 | PIII | Atkins Eric | CFO | A - Grant | $45.05 | +450.5K | 450.5K | New | +$20.30M |
| D | 2021-12-07 | 2021-12-03 | PIII | Price Thomas Edmunds | Dir | A - Grant | $117.77 | +1.18M | 1.18M | New | +$138.69M |
| D | 2021-12-07 | 2021-12-03 | PIII | Bacchus Amir | Chief Medical Off, Dir | A - Grant | $1,503.25 | +15.03M | 15.03M | New | +$22.60B |
| DI | 2021-12-07 | 2021-12-03 | PIII | Bacchus Amir | Chief Medical Off, Dir | A - Grant | $375.81 | +3.76M | 3.76M | New | +$1.41B |
| D | 2021-12-07 | 2021-12-03 | PIII | Kazarian Gregory N. | Dir | A - Grant | $117.77 | +1.18M | 1.18M | New | +$138.69M |
| D | 2021-10-06 | 2021-10-04 | PIII | ZIMMERMAN ROBERT G | Dir | C - Cnv Deriv | — | +25.0K | 25.0K | New | — |
| D | 2021-10-06 | 2021-10-04 | PIII | GAMACHE BRIAN R | Dir | C - Cnv Deriv | — | +25.0K | 25.0K | New | — |
| D | 2021-10-06 | 2021-10-04 | PIII | Foresight Sponsor Group, LLC | 10% | C - Cnv Deriv | — | +6.84M | 7.53M | +1,003% | — |
| DI | 2021-10-06 | 2021-10-04 | PIII | WASSON GREGORY D | Dir, 10% | C - Cnv Deriv | — | +6.84M | 7.53M | +1,003% | — |
| DI | 2021-10-06 | 2021-10-04 | PIII | Balkin Michael | CEO, Dir, 10% | C - Cnv Deriv | — | +6.84M | 7.53M | +1,003% | — |
| D | 2021-10-06 | 2021-10-04 | PIII | SVOBODA JOHN R | Dir | C - Cnv Deriv | — | +25.0K | 25.0K | New | — |
Purchase Sale Sale after option exercise All abbreviations